These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9503527)

  • 1. [Efficacy of immunosorption in patients with systemic lupus erythematosus: double blind controlled trial].
    Amosova EN; Iaremenko OB; Snezhkova EA; Drannik GV
    Ter Arkh; 1997; 69(12):18-22. PubMed ID: 9503527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ; Cambridge G; Edwards JC; Ehrenstein MR; Isenberg DA
    Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.
    Gaubitz M; Seidel M; Kummer S; Schotte H; Perniok A; Domschke W; Schneider M
    J Autoimmun; 1998 Oct; 11(5):495-501. PubMed ID: 9802935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
    J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.
    Steiman AJ; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2010 Sep; 37(9):1822-7. PubMed ID: 20595281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Leandro MJ; Edwards JC; Cambridge G; Ehrenstein MR; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2673-7. PubMed ID: 12384926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of antinuclear antibody negative lupus showing increased proportion of B cells lacking RP105.
    Koarada S; Ide M; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
    J Rheumatol; 2005 Mar; 32(3):562-4. PubMed ID: 15742454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial manifestation by cerebral vasculitis in systemic lupus erythematosus].
    Mrabet D; Meddeb N; Sahli H; Rammeh N; Sellami S
    Tunis Med; 2008 Jun; 86(6):618-9. PubMed ID: 19216467
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy.
    Gao CL; Li BA; Chen CZ; Yu YT; Yuan P; Song JC
    Artif Organs; 1995 May; 19(5):468-9. PubMed ID: 7625928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
    van der Linden MW; Westendorp RG; Zidane M; Meheus L; Huizinga TW
    J Rheumatol; 2001 Feb; 28(2):284-7. PubMed ID: 11246662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
    Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
    J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 15 patients with systemic lupus erythematosus manifesting with negative immunofluorescence anti-nuclear antibodies after treatment.
    Song LJ; Ding F; Liu HX; Shu Q; Yu X; Li J; Li XF
    Lupus; 2012 Jul; 21(8):919-24. PubMed ID: 22187164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I; Dostal C; Becvar R
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.